Related Experiment Video
Updated: Jun 22, 2026

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis
Published on: March 20, 2026
Potential role of vascular targeted therapy to combat against tumor
Bei Chen1, Haifeng Jin, Kaichun Wu
1The Fourth Military Medical University, Xijing Hospital of Digestive Diseases, State Key Laboratory of Cancer Biology, Xi'an, Shaanxi, China.
Abstract:
Tumors, like other tissues, have a fundamental requirement for access to the nutrients, oxygen and waste removal functions of the circulatory system. Vascular targeted therapy exploits this basic need, along with molecular heterogeneity observed between normal and tumor blood vessels, to develop efficient and selective chemotherapies that essentially starve tumors by destroying their vasculature. As the basic principle on which this therapy is based differs from agents that directly target cancerous cells, combining it with traditional therapies such as radiation, surgery and existing chemotherapies has the potential to create powerful new anticancer strategies. As the requirement for vascularization is universal to solid tumors, vascular targeted therapies have the potential for broad applicability. Vascular targeted therapies include both angiogenesis inhibitors, which inhibit neovascularization, and vascular disrupting agents, which destroy existing vasculature. Applications of this model include finding peptides that bind specifically to cell surface markers on tumor vessel endothelial cells and might deliver chemotherapeutic agents. Expression profiling with microarrays, serial analysis of gene expression, and in vitro and in vivo screening of phage display libraries have identified candidate peptides for targeted delivery to the tumor endothelium.
Insights
Vascular targeted therapy offers a novel anticancer strategy by disrupting tumor blood vessels, potentially enhancing traditional treatments. This approach shows broad applicability for solid tumors by selectively targeting their unique vasculature.
Area of Science:
- Oncology
- Vascular Biology
- Drug Discovery
Background:
- Solid tumors rely on the circulatory system for nutrients and waste removal.
- Tumor vasculature exhibits molecular differences compared to normal blood vessels.
- Vascular targeted therapy exploits these differences to selectively attack tumor blood supply.
Purpose of the Study:
- To explore vascular targeted therapy as an anticancer strategy.
- To investigate methods for developing selective chemotherapies that target tumor vasculature.
- To identify potential therapeutic applications by targeting tumor vessel endothelial cells.
Main Methods:
- Utilizing molecular heterogeneity between normal and tumor vasculature.
- Developing angiogenesis inhibitors and vascular disrupting agents.
- Employing expression profiling, gene expression analysis, and phage display libraries to identify targeting peptides.
Main Results:
- Identification of candidate peptides that bind to tumor vessel endothelial cells.
- Demonstration of the potential for targeted delivery of chemotherapeutic agents.
- Validation of vascular targeted therapy as a complementary approach to traditional cancer treatments.
Conclusions:
- Vascular targeted therapy presents a promising and broadly applicable strategy against solid tumors.
- Combining vascular targeted therapy with conventional treatments could yield powerful new anticancer regimens.
- Targeted peptide identification is a key step towards effective vascular targeted drug delivery.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Tumor Immunotherapy
Regulation of Angiogenesis and Blood Supply
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Tumor Microenvironment

